The Pathology Network
PrivateLast Round
Grant
Sep 27, 2022
Total Funding Raised
$100,000
Momentum Score
25 /100
Company Overview
The Pathology Network (TPN) is an Oxford-headquartered, Africa-focused health technology company that operates a digital marketplace to connect patients, doctors, and hospitals across Africa with a global network of specialized laboratories and pathologists. The company's proprietary software platform, Spes360, manages the entire diagnostic workflow, including payments, sample logistics, lab selection, quality control, and results transmission. TPN aims to address the critical shortage of pathologists and diagnostic infrastructure in Africa by leveraging technology, including digital pathology and AI, to provide faster, more affordable, and higher-quality diagnostic services. Founded in Kenya, the company has raised over $1.1 million in funding from impact investors and established a presence in Nairobi, serving numerous hospitals and doctors.
Sector
Healthcare & Life Sciences
Verticals
Revenue Cycle, InsurTech
Business Model
B2B
Customer Profile
Marketplace Commission, Subscription SaaS, Data as a Service
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
The Pathology Network Comps
Public and private peers based on sector, stage, and business model.
The Pathology Network Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Sep 27, 2022 | ||||
| Pre Seed | May 19, 2020 |
The Pathology Network Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Villgro Africa | Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 30, 2025
Attended the 2nd National Cancer Summit organized by the National Cancer Institute of Kenya.
The Pathology Network Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about The Pathology Network's valuation, stock price, and market status.
